117 related articles for article (PubMed ID: 8604740)
1. Intraocular levels of methotrexate after intravenous administration.
de Smet MD; Stark-Vancs V; Kohler DR; Smith J; Wittes R; Nussenblatt RB
Am J Ophthalmol; 1996 Apr; 121(4):442-4. PubMed ID: 8604740
[TBL] [Abstract][Full Text] [Related]
2. High-dose methotrexate for intraocular lymphoma.
Batchelor TT; Kolak G; Ciordia R; Foster CS; Henson JW
Clin Cancer Res; 2003 Feb; 9(2):711-5. PubMed ID: 12576439
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
[TBL] [Abstract][Full Text] [Related]
4. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate.
Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF
Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703
[TBL] [Abstract][Full Text] [Related]
5. Intraocular levels of methotrexate after oral low-dose treatment in chronic uveitis.
Puchta J; Hattenbach LO; Baatz H
Ophthalmologica; 2005; 219(1):54-5. PubMed ID: 15627829
[TBL] [Abstract][Full Text] [Related]
6. Intraocular methotrexate level after high-dose intravenous infusion.
Henson JW; Yang J; Batchelor T
J Clin Oncol; 1999 Apr; 17(4):1329. PubMed ID: 10561199
[No Abstract] [Full Text] [Related]
7. Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate.
Saleh M; Nikolitch K; Bourcier T; Speeg C; Gaucher D
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):761-4. PubMed ID: 21755434
[No Abstract] [Full Text] [Related]
8. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate delivery to the eye using transscleral hydrogel iontophoresis.
Eljarrat-Binstock E; Domb AJ; Orucov F; Frucht-Pery J; Pe'er J
Curr Eye Res; 2007; 32(7-8):639-46. PubMed ID: 17852187
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of plasma total homocysteine in patients receiving high-dose methotrexate therapy.
Guttormsen AB; Ueland PM; Lønning PE; Mella O; Refsum H
Clin Chem; 1998 Sep; 44(9):1987-9. PubMed ID: 9732989
[No Abstract] [Full Text] [Related]
11. [Effects of infusion duration of high-dose methotrexate on cerebrospinal fluid drug levels in lymphoma patients].
Lin XB; Zhou NN; Li S; Cai QQ; Xia ZJ; Liao H; Gao Y; Huang HQ
Ai Zheng; 2008 Oct; 27(10):1100-5. PubMed ID: 18851792
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal methotrexate injections for intraocular involvement in primary central nervous system lymphoma.
Tourville E; Tardif Y
Can J Ophthalmol; 2003 Dec; 38(7):598-601. PubMed ID: 14740803
[No Abstract] [Full Text] [Related]
13. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
Colom H; Farré R; Soy D; Peraire C; Cendros JM; Pardo N; Torrent M; Domenech J; Mangues MA
Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
[TBL] [Abstract][Full Text] [Related]
14. Concurrent administration of intravenous systemic and intravitreal methotrexate for intraocular lymphoma with central nervous system involvement.
Nakauchi Y; Takase H; Sugita S; Mochizuki M; Shibata S; Ishiwata Y; Shibuya Y; Yasuhara M; Miura O; Arai A
Int J Hematol; 2010 Jul; 92(1):179-85. PubMed ID: 20464643
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-10 and interleukin-6 in aqueous humor during treatment of vitreoretinal lymphoma with intravitreally injected methotrexate.
Kawamura H; Yasuda N; Kakinoki M; Sawada T; Sawada O; Ohji M
Ophthalmic Res; 2009; 42(3):172-4. PubMed ID: 19648778
[TBL] [Abstract][Full Text] [Related]
16. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
[TBL] [Abstract][Full Text] [Related]
17. [Leucovorin rescue after continuing infusion of high dose methotrexate].
Yang LH; Lu XT; Gu J; Hua Y; Zhao WH
Zhonghua Er Ke Za Zhi; 2005 May; 43(5):393-4. PubMed ID: 15924763
[No Abstract] [Full Text] [Related]
18. Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma.
Sen HN; Chan CC; Byrnes G; Fariss RN; Nussenblatt RB; Buggage RR
Ocul Immunol Inflamm; 2008; 16(1):29-33. PubMed ID: 18379939
[TBL] [Abstract][Full Text] [Related]
19. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas.
Hiraga S; Arita N; Ohnishi T; Kohmura E; Yamamoto K; Oku Y; Taki T; Sato M; Aozasa K; Yoshimine T
J Neurosurg; 1999 Aug; 91(2):221-30. PubMed ID: 10433310
[TBL] [Abstract][Full Text] [Related]
20. High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?
Glantz MJ; Cole BF; Recht L; Akerley W; Mills P; Saris S; Hochberg F; Calabresi P; Egorin MJ
J Clin Oncol; 1998 Apr; 16(4):1561-7. PubMed ID: 9552066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
